Characterisation and aerosolisation of mannitol particles produced via confined liquid impinging jets.
Mannitol particles, produced by spray drying (SD), have been used commercially (Aridol) in bronchial provocation test. In this study, we propose an alternative method to produce inhalable mannitol powders. The elongated mannitol particles (number median length 4.0microm, and axial ratio of 3.5) were prepared using a confined liquid impinging jets (CLIJs) followed by jet milling (JM). Spray dried and jet milled raw mannitol particles were compared in an attempt to assess the performance of the particles produced by the new method. Aerosol performance of the three different powders (CLIJ, SD, and JM) was relatively poor (fine particle fraction or FPF(loaded) below 15%) when dispersed by the Rotahaler. Dispersion through the Aeroliser led to better aerosol performance of the CLIJ mannitol (FPF(loaded) 20.3%), which is worse than the JM (FPF(loaded) 30.3%) and SD mannitol particles (FPF(loaded) 45.7%) at 60 L/min, but comparable (FPF(loaded) 40.0%) with those of the JM (FPF(loaded) 40.7%) and SD (FPF(loaded) 45.5%) powders at 100L/min. Hence, the optimum use of these elongated mannitol particles can be achieved at increased air flow with a more efficient inhaler. In addition to crystallinity, morphology, and particle size distribution, the surface energies of these powders were measured to explain the differences in aerosol performance. A major advantage of using the CLIJ method is that it can be scaled up with a good yield as the precipitate can be largely collected and recovered on a filter, compared with spray drying which has a low collection efficiency for fine particles below 2microm.
Advanced Drug Delivery Group, Faculty of Pharmacy, The University of Sydney, New South Wales 2006, Australia. kimc@pharm.usyd.edu.au
P
P
Tang
H-K
HK
Chan
H
H
Chiou
K
K
Ogawa
M D
MD
Jones
H
H
Adi
G
G
Buckton
R K
RK
Prud'homme
J A
JA
Raper
D000280:Administration, Inhalation; D000336:Aerosols; D002849:Chromatography, Gas; D003460:Crystallization; D004339:Drug Compounding / Q000379:methods*; D008353:Mannitol / Q000008:administration & dosage* / Q000737:chemistry*; D010316:Particle Size; D011208:Powders; D013499:Surface Properties; D014961:X-Ray Diffraction
D000336:Aerosols; D011208:Powders; D008353:Mannitol